one of these These are the most likely bidders. Pfizer, Aventis, Roche, Genentech, Mayne , Cephalon. There are many which means due to supply and demand forces if many different companies can all use your product with theirs , then your product and company is very valuable and the premium will be larger than many believe could be.
genentech inc., page-6
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $81.83K | 467.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3898006 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2478662 | 37 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |